Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
305.00    0.00 (0.00%)
Bid:
300.00
Ask:
310.00
Spread: 10.00 (3.333%)
Market Cap: £38.70m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Share Dealings

8 Jul 2009 12:46

RNS Number : 3379V
BrainJuicer Group PLC
08 July 2009
Β 

ο»Ώ

Press release

8Β JulyΒ 2009

BrainJuicer Group PLCΒ (AIM: BJU)

("the Company")

Share Dealings

BrainJuicer Group PLCΒ announces that onΒ 8Β JulyΒ 2009, it purchased 30,000 Ordinary SharesΒ into treasuryΒ at a price ofΒ 130Β pence per share in accordance with the authority granted to it by shareholders at the Annual General Meeting held on 13 May 2009. The purchased sharesΒ have beenΒ transferred out ofΒ treasuryΒ to award shares underΒ the Company's Employee Share Incentive Plan. Following the above purchaseΒ and the transfers into and out of treasury, the CompanyΒ continues to haveΒ 12,932,645Β Ordinary Shares in issue (and noΒ treasury shares).

On the same day,Β 8Β July 2009,Β John Kearon, Chief Executive Officer and a director of the Company, soldΒ 30,000Β ordinary shares of 1 pence each in the Company ('Ordinary Shares') at a price ofΒ 130Β pence per Ordinary Share, in orderΒ to satisfyΒ theΒ Company'sΒ need forΒ treasuryΒ shares.

Following this transaction, Mr KearonΒ ownsΒ 5,630,187Β Ordinary Shares, representingΒ 44% of the total issuedΒ share capital of the Company.

The above figure (12,932,645Β Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

- Ends -Β 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com

James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com

Mark Williams / Adria Da BreoΒ Richards

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

Media enquiries:

Abchurch Communications

Tel: +44 (0)20 7398 7714

Heather Salmond / Jack Ballantyne

jack.ballantyne@abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSUWSARKSRBRAR
Date   Source Headline
8th Jul 20264:15 pmRNSDividend Timetable
8th Jul 20267:00 amRNSFinal Results
2nd Jul 20267:00 amRNSNotice of Investor Presentation
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.